David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 293



41
TITLE: O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors
AUTHORS: Makker, V; Colombo, N; Casado Herráez, A; Santin, A; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; Banerjee, S; Monk, B; Ushijima, K; Penson, R; Kristeleit, R; Fabbro, M; Orlando, M; Mackay, H; Ren, M; Orlowski, R; Dutta, L; Lorusso, D;
PUBLISHED: 2021, SOURCE: Oral Abstracts
INDEXED IN: CrossRef: 1
IN MY: ORCID
42
TITLE: O008/#785 A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
AUTHORS: Makker, V; Colombo, N; Casado Herráez, A; Santin, A; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; Baron-Hay, S; Ray-Coquard, I; Shapira, R; Ushijima, K; Sakata, J; Yonemori, K; YM Kim; EM Guerra; UA Sanli; Mccormack, M; Huang, J; AD Smith;
PUBLISHED: 2021, SOURCE: Oral Abstracts
INDEXED IN: CrossRef: 5
IN MY: ORCID
43
TITLE: Outcomes of ovarian cancer patients treated with platinum or non-platinum based chemotherapy after PARP inhibitor maintenance.
AUTHORS: Ralynn Brann; Kevin Michael Kremer; Matthew Carlson; Salvatore LoCoco; Jayanthi Sivasothy Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2021, SOURCE: Journal of Clinical Oncology, VOLUME: 39, ISSUE: 15_suppl
INDEXED IN: CrossRef: 3
IN MY: ORCID
44
TITLE: Ovarian cancer, version 2.2020
AUTHORS: Deborah K Armstrong; Ronald D Alvarez; Jamie N Bakkum Gamez; Lisa Barroilhet; Kian Behbakht; Andrew Berchuck; Lee May Chen; Mihaela Cristea; Maria DeRosa; Eric L Eisenhauer; David M Gershenson; Heidi J Gray; Rachel Grisham; Ardeshir Hakam; Angela Jain; Amer Karam; Gottfried E Konecny; Charles A Leath; Joyce Liu; Haider Mahdi; Lainie Martin; Daniela Matei; Michael McHale; Karen McLean; David Scott Miller ; David M O'Malley; Sanja Percac Lima; Elena Ratner; Steven W Remmenga; Roberto Vargas; Theresa L Werner; Emese Zsiros; Jennifer L Burns; Anita M Engh; ...More
PUBLISHED: 2021, SOURCE: JNCCN Journal of the National Comprehensive Cancer Network, VOLUME: 19, ISSUE: 2
INDEXED IN: Scopus
IN MY: ORCID
45
TITLE: Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
AUTHORS: Deborah K Armstrong; Ronald D Alvarez; Jamie N Bakkum-Gamez; Lisa Barroilhet; Kian Behbakht; Andrew Berchuck; Lee-may Chen; Mihaela Cristea; Maria DeRosa; Eric L Eisenhauer; David M Gershenson; Heidi J Gray; Rachel Grisham; Ardeshir Hakam; Angela Jain; Amer Karam; Gottfried E Konecny; Charles A Leath; Joyce Liu; Haider Mahdi; Lainie Martin; Daniela Matei; Michael McHale; Karen McLean; David Scott Miller ; David M O’Malley; Sanja Percac-Lima; Elena Ratner; Steven W Remmenga; Roberto Vargas; Theresa L Werner; Emese Zsiros; Jennifer L Burns; Anita M Engh; ...More
PUBLISHED: 2021, SOURCE: Journal of the National Comprehensive Cancer Network, VOLUME: 19, ISSUE: 2
INDEXED IN: CrossRef: 329
IN MY: ORCID
46
TITLE: Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study  Full Text
AUTHORS: Ursula A Matulonis; Helen Q Huang; Virginia L Filiaci; Marcus Randall; Paul A DiSilvestro; Katherine M Moxley; Jeffrey M Fowler; Matthew A Powell; Nick M Spirtos; Krishnansu S Tewari; William E Richards; John M Nakayama; David G Mutch; David Scott Miller ; Daniela Matei; Lari B Wenzel;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology
INDEXED IN: Scopus CrossRef: 5
IN MY: ORCID
47
TITLE: Perioperative risk factors and postoperative outcomes following pelvic exenterations for gynecologic versus non-gynecologic malignancies  Full Text
AUTHORS: Alyssa Mercadel; Salvatore Lococo; Matthew Carlson; Jayanthi Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162
INDEXED IN: CrossRef
IN MY: ORCID
48
TITLE: Prognostic factors associated with overall survival in presumed early stage, high-grade serous ovarian cancer: an analysis of the SEER cancer database  Full Text
AUTHORS: Kevin Kremer; Matthew Carlson; Jessica Lee; Salvatore Lococo; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162
INDEXED IN: CrossRef: 1
IN MY: ORCID
49
TITLE: Risk factors associated with 30-day postoperative complications following contemporary pelvic exenterations for gynecologic cancer  Full Text
AUTHORS: Alyssa Mercadel; Alexandra Spirtos; Salvatore Lococo; Matthew Carlson; Jayanthi Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162
INDEXED IN: CrossRef
IN MY: ORCID
50
TITLE: Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors  Full Text
AUTHORS: Mitzi Aguilar; He Zhang; Musi Zhang; Brandi Cantarell; Subhransu S Sahoo; Hao Dong Li; Ileana C Cuevas; Jayanthi Lea; David Scott Miller ; Hao Chen; Wenxin Zheng; Jeffrey Gagan; Elena Lucas; Diego H Castrillon;
PUBLISHED: 2021, SOURCE: Journal of Pathology, VOLUME: 254, ISSUE: 1
INDEXED IN: Scopus CrossRef: 6
IN MY: ORCID
Page 5 of 30. Total results: 293.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service